Sofosbuvir+Velpatasvir

DRUG2 trials

Sponsors

FixHepC, Fondazione Italiana Linfomi - ETS

Conditions

Hepatitis CIndolent B-cell Lymphoma

Phase 2

Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir for Pts With Indolent Bcell Lymphoma Associated With HCV Infection

CompletedNCT02836925

Fondazione Italiana Linfomi - ETSHepatitis C, Indolent B-cell Lymphoma

Start: 2016-03-31End: 2022-11-30Updated: 2023-03-31

Unknown Phase

Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods

FixHepCHepatitis C

Start: 2015-07-01End: 2018-06-30Target: 10000Updated: 2017-02-16

Related Papers

DIRECT‐ACTING ANTIVIRALS AS PRIMARY TREATMENT FOR HCV‐ASSOCIATED INDOLENT NON‐HODGKIN LYMPHOMAS: THE PROSPECTIVE BART STUDY OF THE <i>FONDAZIONE ITALIANA LINFOMI</i>

Hematological Oncology2021-06-01